Applied Clinical Trials-04-01-2008

The Drug Information Association hosted its 20th Annual European meeting in Barcelona, Spain, where industry experts discussed topics at the forefront of European pharma.

When done right, pooling clinical supplies can increase efficiency and contain costs, but limitations exist.

How one patient community on the Web is single-handedly forging new ground in the clinical trials world.

Award for excellence in human research protection is the incentive for better oversight and regulations.

Ketek probe raises questions about research oversight by FDA, sponsors, and investigators.

News tidbits from around the world

A recent survey from KMR Group shows a 15% decline in clinical operations productivity since 2005.

A recent survey uncovers key criteria that influence a sponsor's decision when selecting a CRO.

For the first time n a Phase 1 trial, 3D animation is used for informed consent.

Europe aims to create new regulations regarding hematological malignancies.

With globalization of trials comes the difficulties of sample logistics. Enter the central laboratory model.

Dr. Steve Dodsworth, director of molecular genetic services for Tepnel Research Products & Services, assesses that with molecular insight comes the opportunity to counter disease development and progression.

Since 1993, investments from big pharma have helped develop a solid infrastructure favorable to CROs.

A look at the latest industry news

Janet Woodcock is welcomed back as the director of the Center for Drug Evaluation and Research (CDER).

New regulations prompt the EU to request more info from sponsors on clinical trial applications.